T2 Biosystems, Inc.
T2 Biosystems, Inc. TTOO Peers
See (TTOO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TTOO | $0.10 | +809.09% | 2.8M | -3.33 | -$0.03 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.62% |
| TMO | $427.62 | +5.60% | 161.2B | 25.05 | $17.05 | +0.38% |
| DHR | $189.91 | +0.98% | 135.9B | 36.87 | $5.15 | +0.62% |
| IDXX | $532.00 | +2.14% | 42.8B | 49.21 | $10.81 | N/A |
| A | $116.19 | +3.70% | 33B | 28.63 | $4.06 | +0.84% |
| IQV | $187.38 | +17.88% | 32.4B | 25.56 | $7.33 | N/A |
| MTD | $1,218.96 | +4.50% | 25.4B | 30.45 | $40.06 | N/A |
| DGX | $178.24 | +7.08% | 19.9B | 22.53 | $7.91 | +1.75% |
| NTRA | $139.92 | -0.50% | 19.1B | -95.18 | -$1.47 | N/A |
Stock Comparison
TTOO vs DHR-PB Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, TTOO is priced at $0.10, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, TTOO's ROE is +2.06%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, TTOO is less volatile compared to DHR-PB. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs TMO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, TMO has a market cap of 161.2B. Regarding current trading prices, TTOO is priced at $0.10, while TMO trades at $427.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas TMO's P/E ratio is 25.05. In terms of profitability, TTOO's ROE is +2.06%, compared to TMO's ROE of +0.13%. Regarding short-term risk, TTOO is less volatile compared to TMO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs DHR Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DHR has a market cap of 135.9B. Regarding current trading prices, TTOO is priced at $0.10, while DHR trades at $189.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DHR's P/E ratio is 36.87. In terms of profitability, TTOO's ROE is +2.06%, compared to DHR's ROE of +0.07%. Regarding short-term risk, TTOO is less volatile compared to DHR. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs IDXX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, IDXX has a market cap of 42.8B. Regarding current trading prices, TTOO is priced at $0.10, while IDXX trades at $532.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas IDXX's P/E ratio is 49.21. In terms of profitability, TTOO's ROE is +2.06%, compared to IDXX's ROE of +0.57%. Regarding short-term risk, TTOO is less volatile compared to IDXX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs A Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, A has a market cap of 33B. Regarding current trading prices, TTOO is priced at $0.10, while A trades at $116.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas A's P/E ratio is 28.63. In terms of profitability, TTOO's ROE is +2.06%, compared to A's ROE of +0.19%. Regarding short-term risk, TTOO is less volatile compared to A. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs IQV Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, IQV has a market cap of 32.4B. Regarding current trading prices, TTOO is priced at $0.10, while IQV trades at $187.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas IQV's P/E ratio is 25.56. In terms of profitability, TTOO's ROE is +2.06%, compared to IQV's ROE of +0.20%. Regarding short-term risk, TTOO is less volatile compared to IQV. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MTD Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MTD has a market cap of 25.4B. Regarding current trading prices, TTOO is priced at $0.10, while MTD trades at $1,218.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MTD's P/E ratio is 30.45. In terms of profitability, TTOO's ROE is +2.06%, compared to MTD's ROE of +1.21%. Regarding short-term risk, TTOO is less volatile compared to MTD. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs DGX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DGX has a market cap of 19.9B. Regarding current trading prices, TTOO is priced at $0.10, while DGX trades at $178.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DGX's P/E ratio is 22.53. In terms of profitability, TTOO's ROE is +2.06%, compared to DGX's ROE of +0.18%. Regarding short-term risk, TTOO is less volatile compared to DGX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NTRA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NTRA has a market cap of 19.1B. Regarding current trading prices, TTOO is priced at $0.10, while NTRA trades at $139.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NTRA's P/E ratio is -95.18. In terms of profitability, TTOO's ROE is +2.06%, compared to NTRA's ROE of -0.18%. Regarding short-term risk, TTOO is less volatile compared to NTRA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs WAT Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, WAT has a market cap of 17.1B. Regarding current trading prices, TTOO is priced at $0.10, while WAT trades at $287.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas WAT's P/E ratio is 26.08. In terms of profitability, TTOO's ROE is +2.06%, compared to WAT's ROE of +0.39%. Regarding short-term risk, TTOO is less volatile compared to WAT. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ILMN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ILMN has a market cap of 16.2B. Regarding current trading prices, TTOO is priced at $0.10, while ILMN trades at $102.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ILMN's P/E ratio is -16.79. In terms of profitability, TTOO's ROE is +2.06%, compared to ILMN's ROE of -0.46%. Regarding short-term risk, TTOO is less volatile compared to ILMN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs PKI Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, TTOO is priced at $0.10, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PKI's P/E ratio is 41.45. In terms of profitability, TTOO's ROE is +2.06%, compared to PKI's ROE of +0.04%. Regarding short-term risk, TTOO is less volatile compared to PKI. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MEDP Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MEDP has a market cap of 13.7B. Regarding current trading prices, TTOO is priced at $0.10, while MEDP trades at $477.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MEDP's P/E ratio is 36.47. In terms of profitability, TTOO's ROE is +2.06%, compared to MEDP's ROE of +0.68%. Regarding short-term risk, TTOO is less volatile compared to MEDP. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ICLR Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ICLR has a market cap of 13B. Regarding current trading prices, TTOO is priced at $0.10, while ICLR trades at $161.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ICLR's P/E ratio is 17.61. In terms of profitability, TTOO's ROE is +2.06%, compared to ICLR's ROE of +0.08%. Regarding short-term risk, TTOO is less volatile compared to ICLR. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs RVTY Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, RVTY has a market cap of 11.3B. Regarding current trading prices, TTOO is priced at $0.10, while RVTY trades at $96.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas RVTY's P/E ratio is 39.72. In terms of profitability, TTOO's ROE is +2.06%, compared to RVTY's ROE of +0.04%. Regarding short-term risk, TTOO is less volatile compared to RVTY. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs QGEN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, QGEN has a market cap of 10.7B. Regarding current trading prices, TTOO is priced at $0.10, while QGEN trades at $49.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas QGEN's P/E ratio is 115.16. In terms of profitability, TTOO's ROE is +2.06%, compared to QGEN's ROE of +0.03%. Regarding short-term risk, TTOO is less volatile compared to QGEN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs TEM Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, TEM has a market cap of 10.3B. Regarding current trading prices, TTOO is priced at $0.10, while TEM trades at $61.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas TEM's P/E ratio is -11.84. In terms of profitability, TTOO's ROE is +2.06%, compared to TEM's ROE of -5.31%. Regarding short-term risk, TTOO is less volatile compared to TEM. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs EXAS Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, EXAS has a market cap of 9.4B. Regarding current trading prices, TTOO is priced at $0.10, while EXAS trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas EXAS's P/E ratio is -9.01. In terms of profitability, TTOO's ROE is +2.06%, compared to EXAS's ROE of -0.36%. Regarding short-term risk, TTOO is less volatile compared to EXAS. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CRL Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CRL has a market cap of 8B. Regarding current trading prices, TTOO is priced at $0.10, while CRL trades at $163.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CRL's P/E ratio is -263.37. In terms of profitability, TTOO's ROE is +2.06%, compared to CRL's ROE of -0.01%. Regarding short-term risk, TTOO is less volatile compared to CRL. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs GH Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, GH has a market cap of 5.7B. Regarding current trading prices, TTOO is priced at $0.10, while GH trades at $46.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas GH's P/E ratio is -13.64. In terms of profitability, TTOO's ROE is +2.06%, compared to GH's ROE of +3.69%. Regarding short-term risk, TTOO is less volatile compared to GH. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs SYNH Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, TTOO is priced at $0.10, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas SYNH's P/E ratio is 61.40. In terms of profitability, TTOO's ROE is +2.06%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, TTOO is less volatile compared to SYNH. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs RDNT Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, RDNT has a market cap of 4.4B. Regarding current trading prices, TTOO is priced at $0.10, while RDNT trades at $57.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas RDNT's P/E ratio is -132.88. In terms of profitability, TTOO's ROE is +2.06%, compared to RDNT's ROE of +0.03%. Regarding short-term risk, TTOO is less volatile compared to RDNT. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs OLK Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, TTOO is priced at $0.10, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas OLK's P/E ratio is -96.59. In terms of profitability, TTOO's ROE is +2.06%, compared to OLK's ROE of -0.07%. Regarding short-term risk, TTOO is less volatile compared to OLK. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs SHC Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, SHC has a market cap of 3.2B. Regarding current trading prices, TTOO is priced at $0.10, while SHC trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas SHC's P/E ratio is 126.22. In terms of profitability, TTOO's ROE is +2.06%, compared to SHC's ROE of +0.06%. Regarding short-term risk, TTOO is less volatile compared to SHC. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs TWST Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, TWST has a market cap of 2.1B. Regarding current trading prices, TTOO is priced at $0.10, while TWST trades at $35.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas TWST's P/E ratio is -11.02. In terms of profitability, TTOO's ROE is +2.06%, compared to TWST's ROE of -0.41%. Regarding short-term risk, TTOO is less volatile compared to TWST. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs VIVO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, VIVO has a market cap of 1.5B. Regarding current trading prices, TTOO is priced at $0.10, while VIVO trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas VIVO's P/E ratio is 21.09. In terms of profitability, TTOO's ROE is +2.06%, compared to VIVO's ROE of +0.12%. Regarding short-term risk, TTOO is less volatile compared to VIVO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs GRAL Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, GRAL has a market cap of 1.3B. Regarding current trading prices, TTOO is priced at $0.10, while GRAL trades at $37.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas GRAL's P/E ratio is -0.62. In terms of profitability, TTOO's ROE is +2.06%, compared to GRAL's ROE of -0.75%. Regarding short-term risk, TTOO is less volatile compared to GRAL. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs OPK Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, OPK has a market cap of 1.1B. Regarding current trading prices, TTOO is priced at $0.10, while OPK trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas OPK's P/E ratio is -23.08. In terms of profitability, TTOO's ROE is +2.06%, compared to OPK's ROE of -0.03%. Regarding short-term risk, TTOO is less volatile compared to OPK. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NEOG Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NEOG has a market cap of 1.1B. Regarding current trading prices, TTOO is priced at $0.10, while NEOG trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NEOG's P/E ratio is -2.25. In terms of profitability, TTOO's ROE is +2.06%, compared to NEOG's ROE of -0.17%. Regarding short-term risk, TTOO is less volatile compared to NEOG. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CDNA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CDNA has a market cap of 725M. Regarding current trading prices, TTOO is priced at $0.10, while CDNA trades at $13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CDNA's P/E ratio is 11.62. In terms of profitability, TTOO's ROE is +2.06%, compared to CDNA's ROE of +0.18%. Regarding short-term risk, TTOO is less volatile compared to CDNA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs GRALV Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, TTOO is priced at $0.10, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas GRALV's P/E ratio is N/A. In terms of profitability, TTOO's ROE is +2.06%, compared to GRALV's ROE of N/A. Regarding short-term risk, TTOO is less volatile compared to GRALV. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs PSNL Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PSNL has a market cap of 567.9M. Regarding current trading prices, TTOO is priced at $0.10, while PSNL trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PSNL's P/E ratio is -4.98. In terms of profitability, TTOO's ROE is +2.06%, compared to PSNL's ROE of -0.49%. Regarding short-term risk, TTOO is less volatile compared to PSNL. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs FLGT Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, FLGT has a market cap of 567.2M. Regarding current trading prices, TTOO is priced at $0.10, while FLGT trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas FLGT's P/E ratio is -14.01. In terms of profitability, TTOO's ROE is +2.06%, compared to FLGT's ROE of -0.04%. Regarding short-term risk, TTOO is less volatile compared to FLGT. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs LAB Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, LAB has a market cap of 516.6M. Regarding current trading prices, TTOO is priced at $0.10, while LAB trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas LAB's P/E ratio is -4.25. In terms of profitability, TTOO's ROE is +2.06%, compared to LAB's ROE of -0.28%. Regarding short-term risk, TTOO is less volatile compared to LAB. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CSTL Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CSTL has a market cap of 471.2M. Regarding current trading prices, TTOO is priced at $0.10, while CSTL trades at $16.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CSTL's P/E ratio is -85.89. In terms of profitability, TTOO's ROE is +2.06%, compared to CSTL's ROE of -0.01%. Regarding short-term risk, TTOO is less volatile compared to CSTL. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MYGN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MYGN has a market cap of 423.1M. Regarding current trading prices, TTOO is priced at $0.10, while MYGN trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MYGN's P/E ratio is -4.10. In terms of profitability, TTOO's ROE is +2.06%, compared to MYGN's ROE of -0.14%. Regarding short-term risk, TTOO is less volatile compared to MYGN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, TTOO is priced at $0.10, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CO's P/E ratio is 5.06. In terms of profitability, TTOO's ROE is +2.06%, compared to CO's ROE of +0.11%. Regarding short-term risk, TTOO is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs FLDM Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, TTOO is priced at $0.10, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas FLDM's P/E ratio is -4.74. In terms of profitability, TTOO's ROE is +2.06%, compared to FLDM's ROE of -0.28%. Regarding short-term risk, TTOO is less volatile compared to FLDM. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs STIM Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, STIM has a market cap of 279M. Regarding current trading prices, TTOO is priced at $0.10, while STIM trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas STIM's P/E ratio is -3.20. In terms of profitability, TTOO's ROE is +2.06%, compared to STIM's ROE of -2.09%. Regarding short-term risk, TTOO is less volatile compared to STIM. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ACRS Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ACRS has a market cap of 176M. Regarding current trading prices, TTOO is priced at $0.10, while ACRS trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ACRS's P/E ratio is -1.03. In terms of profitability, TTOO's ROE is +2.06%, compared to ACRS's ROE of -0.92%. Regarding short-term risk, TTOO is less volatile compared to ACRS. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NEO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NEO has a market cap of 165.2M. Regarding current trading prices, TTOO is priced at $0.10, while NEO trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NEO's P/E ratio is -10.52. In terms of profitability, TTOO's ROE is +2.06%, compared to NEO's ROE of -0.09%. Regarding short-term risk, TTOO is less volatile compared to NEO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs XGN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, XGN has a market cap of 151.7M. Regarding current trading prices, TTOO is priced at $0.10, while XGN trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas XGN's P/E ratio is -8.26. In terms of profitability, TTOO's ROE is +2.06%, compared to XGN's ROE of -1.34%. Regarding short-term risk, TTOO is less volatile compared to XGN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs GTH Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, TTOO is priced at $0.10, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas GTH's P/E ratio is -1.11. In terms of profitability, TTOO's ROE is +2.06%, compared to GTH's ROE of -1.01%. Regarding short-term risk, TTOO is less volatile compared to GTH. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MDXH Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MDXH has a market cap of 118.8M. Regarding current trading prices, TTOO is priced at $0.10, while MDXH trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MDXH's P/E ratio is -2.31. In terms of profitability, TTOO's ROE is +2.06%, compared to MDXH's ROE of -5.35%. Regarding short-term risk, TTOO is less volatile compared to MDXH. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ATLN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ATLN has a market cap of 112.2M. Regarding current trading prices, TTOO is priced at $0.10, while ATLN trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ATLN's P/E ratio is -0.49. In terms of profitability, TTOO's ROE is +2.06%, compared to ATLN's ROE of -42.96%. Regarding short-term risk, TTOO is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs GENE Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, TTOO is priced at $0.10, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas GENE's P/E ratio is -38.25. In terms of profitability, TTOO's ROE is +2.06%, compared to GENE's ROE of -3.62%. Regarding short-term risk, TTOO and GENE have similar daily volatility (0.00).
TTOO vs PRE Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PRE has a market cap of 106.2M. Regarding current trading prices, TTOO is priced at $0.10, while PRE trades at $8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PRE's P/E ratio is -2.14. In terms of profitability, TTOO's ROE is +2.06%, compared to PRE's ROE of -0.28%. Regarding short-term risk, TTOO is less volatile compared to PRE. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs SERA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, SERA has a market cap of 105.7M. Regarding current trading prices, TTOO is priced at $0.10, while SERA trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas SERA's P/E ratio is -3.06. In terms of profitability, TTOO's ROE is +2.06%, compared to SERA's ROE of -0.51%. Regarding short-term risk, TTOO is less volatile compared to SERA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs PRENW Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PRENW has a market cap of 105.2M. Regarding current trading prices, TTOO is priced at $0.10, while PRENW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PRENW's P/E ratio is N/A. In terms of profitability, TTOO's ROE is +2.06%, compared to PRENW's ROE of -0.28%. Regarding short-term risk, TTOO is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs VNRX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, VNRX has a market cap of 78M. Regarding current trading prices, TTOO is priced at $0.10, while VNRX trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas VNRX's P/E ratio is -2.78. In terms of profitability, TTOO's ROE is +2.06%, compared to VNRX's ROE of +1.08%. Regarding short-term risk, TTOO is less volatile compared to VNRX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NOTV Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NOTV has a market cap of 72.1M. Regarding current trading prices, TTOO is priced at $0.10, while NOTV trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NOTV's P/E ratio is -0.67. In terms of profitability, TTOO's ROE is +2.06%, compared to NOTV's ROE of -0.51%. Regarding short-term risk, TTOO is less volatile compared to NOTV. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BDSX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BDSX has a market cap of 52.8M. Regarding current trading prices, TTOO is priced at $0.10, while BDSX trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BDSX's P/E ratio is -1.33. In terms of profitability, TTOO's ROE is +2.06%, compared to BDSX's ROE of -1.68%. Regarding short-term risk, TTOO is less volatile compared to BDSX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs OPGN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, OPGN has a market cap of 47.3M. Regarding current trading prices, TTOO is priced at $0.10, while OPGN trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas OPGN's P/E ratio is -0.30. In terms of profitability, TTOO's ROE is +2.06%, compared to OPGN's ROE of +1.20%. Regarding short-term risk, TTOO is less volatile compared to OPGN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs DRIO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DRIO has a market cap of 31.1M. Regarding current trading prices, TTOO is priced at $0.10, while DRIO trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DRIO's P/E ratio is -1.27. In terms of profitability, TTOO's ROE is +2.06%, compared to DRIO's ROE of -0.17%. Regarding short-term risk, TTOO is less volatile compared to DRIO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs STRRP Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, STRRP has a market cap of 29.4M. Regarding current trading prices, TTOO is priced at $0.10, while STRRP trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas STRRP's P/E ratio is -4.58. In terms of profitability, TTOO's ROE is +2.06%, compared to STRRP's ROE of -0.24%. Regarding short-term risk, TTOO and STRRP have similar daily volatility (0.00).
TTOO vs AKU Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, TTOO is priced at $0.10, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas AKU's P/E ratio is -0.13. In terms of profitability, TTOO's ROE is +2.06%, compared to AKU's ROE of -5.32%. Regarding short-term risk, TTOO is less volatile compared to AKU. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs PRPO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PRPO has a market cap of 21.3M. Regarding current trading prices, TTOO is priced at $0.10, while PRPO trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PRPO's P/E ratio is -6.84. In terms of profitability, TTOO's ROE is +2.06%, compared to PRPO's ROE of -0.26%. Regarding short-term risk, TTOO is less volatile compared to PRPO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CEMI Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, TTOO is priced at $0.10, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CEMI's P/E ratio is -0.63. In terms of profitability, TTOO's ROE is +2.06%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, TTOO and CEMI have similar daily volatility (0.00).
TTOO vs ENZ Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, TTOO is priced at $0.10, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ENZ's P/E ratio is -2.24. In terms of profitability, TTOO's ROE is +2.06%, compared to ENZ's ROE of -0.44%. Regarding short-term risk, TTOO is less volatile compared to ENZ. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs PMD Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, PMD has a market cap of 15.7M. Regarding current trading prices, TTOO is priced at $0.10, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas PMD's P/E ratio is -5.24. In terms of profitability, TTOO's ROE is +2.06%, compared to PMD's ROE of -0.33%. Regarding short-term risk, TTOO is less volatile compared to PMD. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs INBS Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, INBS has a market cap of 15.5M. Regarding current trading prices, TTOO is priced at $0.10, while INBS trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas INBS's P/E ratio is -1.69. In terms of profitability, TTOO's ROE is +2.06%, compared to INBS's ROE of -1.72%. Regarding short-term risk, TTOO is less volatile compared to INBS. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ADVB Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ADVB has a market cap of 13.6M. Regarding current trading prices, TTOO is priced at $0.10, while ADVB trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ADVB's P/E ratio is -3.92. In terms of profitability, TTOO's ROE is +2.06%, compared to ADVB's ROE of -1.86%. Regarding short-term risk, TTOO is less volatile compared to ADVB. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ME Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ME has a market cap of 13.3M. Regarding current trading prices, TTOO is priced at $0.10, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ME's P/E ratio is -0.03. In terms of profitability, TTOO's ROE is +2.06%, compared to ME's ROE of -3.99%. Regarding short-term risk, TTOO is less volatile compared to ME. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BNGO Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BNGO has a market cap of 11.9M. Regarding current trading prices, TTOO is priced at $0.10, while BNGO trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BNGO's P/E ratio is -0.07. In terms of profitability, TTOO's ROE is +2.06%, compared to BNGO's ROE of -1.57%. Regarding short-term risk, TTOO is less volatile compared to BNGO. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BIAF Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BIAF has a market cap of 9.8M. Regarding current trading prices, TTOO is priced at $0.10, while BIAF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BIAF's P/E ratio is -0.48. In terms of profitability, TTOO's ROE is +2.06%, compared to BIAF's ROE of -3.68%. Regarding short-term risk, TTOO is less volatile compared to BIAF. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BIAFW Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BIAFW has a market cap of 9.3M. Regarding current trading prices, TTOO is priced at $0.10, while BIAFW trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BIAFW's P/E ratio is N/A. In terms of profitability, TTOO's ROE is +2.06%, compared to BIAFW's ROE of -3.68%. Regarding short-term risk, TTOO and BIAFW have similar daily volatility (0.00).
TTOO vs CNTG Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CNTG has a market cap of 9.2M. Regarding current trading prices, TTOO is priced at $0.10, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CNTG's P/E ratio is -0.23. In terms of profitability, TTOO's ROE is +2.06%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, TTOO is less volatile compared to CNTG. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BGLC Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BGLC has a market cap of 9.1M. Regarding current trading prices, TTOO is priced at $0.10, while BGLC trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BGLC's P/E ratio is -4.25. In terms of profitability, TTOO's ROE is +2.06%, compared to BGLC's ROE of -0.24%. Regarding short-term risk, TTOO is less volatile compared to BGLC. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MYNZ Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MYNZ has a market cap of 7.6M. Regarding current trading prices, TTOO is priced at $0.10, while MYNZ trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MYNZ's P/E ratio is -0.09. In terms of profitability, TTOO's ROE is +2.06%, compared to MYNZ's ROE of -22.70%. Regarding short-term risk, TTOO is less volatile compared to MYNZ. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs TRIB Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, TRIB has a market cap of 7.5M. Regarding current trading prices, TTOO is priced at $0.10, while TRIB trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas TRIB's P/E ratio is -0.40. In terms of profitability, TTOO's ROE is +2.06%, compared to TRIB's ROE of +1.12%. Regarding short-term risk, TTOO is less volatile compared to TRIB. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs STRR Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, STRR has a market cap of 6.8M. Regarding current trading prices, TTOO is priced at $0.10, while STRR trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas STRR's P/E ratio is -0.71. In terms of profitability, TTOO's ROE is +2.06%, compared to STRR's ROE of -0.24%. Regarding short-term risk, TTOO is less volatile compared to STRR. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs BNR Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BNR has a market cap of 6.3M. Regarding current trading prices, TTOO is priced at $0.10, while BNR trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BNR's P/E ratio is -1.81. In terms of profitability, TTOO's ROE is +2.06%, compared to BNR's ROE of -0.39%. Regarding short-term risk, TTOO is less volatile compared to BNR. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NVTA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, TTOO is priced at $0.10, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NVTA's P/E ratio is -0.00. In terms of profitability, TTOO's ROE is +2.06%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, TTOO is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs LMDX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, TTOO is priced at $0.10, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas LMDX's P/E ratio is -0.01. In terms of profitability, TTOO's ROE is +2.06%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, TTOO is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs LMDXW Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, TTOO is priced at $0.10, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, TTOO's ROE is +2.06%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, TTOO is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs NDRA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, NDRA has a market cap of 4.9M. Regarding current trading prices, TTOO is priced at $0.10, while NDRA trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas NDRA's P/E ratio is 0.02. In terms of profitability, TTOO's ROE is +2.06%, compared to NDRA's ROE of -1.96%. Regarding short-term risk, TTOO is less volatile compared to NDRA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs CHEK Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, CHEK has a market cap of 4.5M. Regarding current trading prices, TTOO is priced at $0.10, while CHEK trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas CHEK's P/E ratio is -0.36. In terms of profitability, TTOO's ROE is +2.06%, compared to CHEK's ROE of -0.52%. Regarding short-term risk, TTOO is less volatile compared to CHEK. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs DMTK Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, TTOO is priced at $0.10, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DMTK's P/E ratio is -0.04. In terms of profitability, TTOO's ROE is +2.06%, compared to DMTK's ROE of -0.80%. Regarding short-term risk, TTOO is less volatile compared to DMTK. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs AWH Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, AWH has a market cap of 2.9M. Regarding current trading prices, TTOO is priced at $0.10, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas AWH's P/E ratio is -0.09. In terms of profitability, TTOO's ROE is +2.06%, compared to AWH's ROE of +4.66%. Regarding short-term risk, TTOO is less volatile compared to AWH. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs APDN Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, APDN has a market cap of 2.7M. Regarding current trading prices, TTOO is priced at $0.10, while APDN trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas APDN's P/E ratio is N/A. In terms of profitability, TTOO's ROE is +2.06%, compared to APDN's ROE of -2.81%. Regarding short-term risk, TTOO is less volatile compared to APDN. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs ISPC Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, ISPC has a market cap of 2.6M. Regarding current trading prices, TTOO is priced at $0.10, while ISPC trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas ISPC's P/E ratio is -0.09. In terms of profitability, TTOO's ROE is +2.06%, compared to ISPC's ROE of -2.85%. Regarding short-term risk, TTOO is less volatile compared to ISPC. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs SQL Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, TTOO is priced at $0.10, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas SQL's P/E ratio is -0.40. In terms of profitability, TTOO's ROE is +2.06%, compared to SQL's ROE of +10.89%. Regarding short-term risk, TTOO is less volatile compared to SQL. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs HTGM Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, TTOO is priced at $0.10, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas HTGM's P/E ratio is -0.03. In terms of profitability, TTOO's ROE is +2.06%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, TTOO and HTGM have similar daily volatility (0.00).
TTOO vs BIOC Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, TTOO is priced at $0.10, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas BIOC's P/E ratio is -0.01. In terms of profitability, TTOO's ROE is +2.06%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, TTOO is less volatile compared to BIOC. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs SQLLW Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, SQLLW has a market cap of 117.9K. Regarding current trading prices, TTOO is priced at $0.10, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, TTOO's ROE is +2.06%, compared to SQLLW's ROE of -42.96%. Regarding short-term risk, TTOO and SQLLW have similar daily volatility (0.00).
TTOO vs DHR-PA Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, TTOO is priced at $0.10, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, TTOO's ROE is +2.06%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, TTOO is less volatile compared to DHR-PA. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs OCDX Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, TTOO is priced at $0.10, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas OCDX's P/E ratio is -42.28. In terms of profitability, TTOO's ROE is +2.06%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, TTOO is less volatile compared to OCDX. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.
TTOO vs MEUSW Comparison
TTOO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTOO stands at 2.8M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, TTOO is priced at $0.10, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTOO currently has a P/E ratio of -3.33, whereas MEUSW's P/E ratio is N/A. In terms of profitability, TTOO's ROE is +2.06%, compared to MEUSW's ROE of -3.99%. Regarding short-term risk, TTOO is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for TTOO.